References
- Kerrigan CL, Daniel RK. Pharmacologic treatment of the failing skin flap. Plast Reconstr Surg 1982;70:541–9.
- Kerrigan CL. Skin flap failure: pathophysiology. Plast Reconstr Surg 1983;72:766–77.
- Kerrigan CL, Hjortdal VE. Skin flap physiology and pathophysiology. In Barrdach J, editor. Local flaps and free skin grafts. St. Louis, MO: Mosby; 1992. p 24–41.
- Tamir G, Yaffe S, Pri-Chen S. The effect of allopurinol on experimental island skin flap survival under prolonged periods of arterial ischemia. Br J Plast Surg 1994;47:155–7.
- Stadelmann WK, Hess DB, Robson MC. Aprotinin in ischemia-reperfusion injury: flap survival and neutrofil response in a rat skin flap model. Microsurgery 1998;18:354–61.
- Hayden RE, Paniello RC, Yeung CS. The effect of glutathione and vitamins A, C, and E on acute skin flap survival. Laryngoscope 1987;97:1176–9.
- Green CJ, Dhami L, Prasad S. The effect of desferrioxamine on lipid peroxidation and survival of ischaemic island skin flaps in rats. Br J Plast Surg 1989;42:565–9.
- Kim YS, Im MJ, Hoopes JE. The effect of a free-radical scavenger, N-2-mercaptopropionylglycine, on the survival of skin flaps. Ann Plast Surg 1990;25:18–20.
- Suzuki S, Matsushita Y, Isshiki N. Salvage of distal flap necrosis by topical superoxide dismutase. Ann Plast Surg 1991;27:253–7.
- Shah DK, Zhang WX, Forman DL. Combination therapy for salvaging a failing, experimental skin flap. J Reconstr Microsurg 1996;12:365–9.
- Bekercioğlu M, Tercan M, Ozyazgan I. The effect of Gingko biloba extract (Egb 761) as free radical scavenger on the survival of skin flaps in rats. A comparative study. Scand J Plast Reconstr Surg Hand Surg 1998;32:135–9.
- Corbin JD, Francis SH, Webb DJ. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. Urology 2002;60:4–11.
- Giovannoni MP, Vergelli C, Graziano A. PDE5 inhibitors and their applications. Curr Med Chem 2010;17:2564–87.
- Ng WK, Rosenblatt Y, Brock GB. Phosphodiesterase inhibitors in vascular ischemia: a case report and review of their use in ischemic conditions. Can J Plast Surg 2010;18:e5–9.
- Gravvanis A, Papalois A, Delikonstantinou I. Changes in arterial blood flow of free flaps after the administration of sildenafil in swine. Microsurgery 2011;31:465–71.
- Cheitlin MD, Hutter AMJr, Brindis RG. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol 1999;33:273–82.
- Mostafa T. Oral phosphodiesterase type 5 inhibitors: nonerectogenic beneficial uses. J Sex Med 2008;5:2502–18.
- Sarifakioglu N, Gokrem S, Ates L. The influence of sildenafil on random skin flap survival in rats: an experimental study. Br J Plast Surg 2004;57:769–72.
- Ayyildiz A, Uysal A, Koçer U. Effect of sildenafil citrate on viability of flaps: an experimental study in rats. Scand J Plast Reconstr Surg Hand Surg 2005;39:204–8.
- Ulusoy MG, Uysal A, Koçer U. Improved flap viability with site-specific delivery of sildenafil citrate using fibrin glue. Ann Plast Surg 2005;55:292–6.
- Hart K, Baur D, Hodam J. Short- and long-term effects of sildenafil on skin flap survival in rats. Laryngoscope 2006;116:522–8.
- Tsai JW, Ayubi FS, Hart KL. Evaluation of the effect of sildenafil and vascular endothelium growth factor combination treatment on skin flap survival in rats. Aesthetic Plast Surg 2008;32:624–31.
- Barral SM, Araujo ID, Vidigal PV. Effects of sildenafil on the viability of random skin flaps. Acta Cir Bras 2011;26:314–19.
- Brewer MB, Stump AL, Holton LH. Effects of systemic tadalafil on skin flap survival in rats. Eplasty 2012;12:e45.
- Oh M, Chang H, Minn KW. The effects of tadalafil on axial-pattern skin flap survival in rats. Dermatol Surg 2008;34:626–30.
- Bandera BC, Pham T, Hill-Pryor C. Role of growth factors in improved skin flap viability caused by phosphodiesterase-5 inhibitor. Am Surg 2010;76:614–17.